Apellis Pharmaceuticals: Q4 Earnings Insights

Apellis Pharmaceuticals APLS reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Apellis Pharmaceuticals missed estimated earnings by 4.55%, reporting an EPS of $-1.61 versus an estimate of $-1.54.

Revenue was up $189.71 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.18 which was followed by a 10.83% increase in the share price the next day.

Here's a look at Apellis Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.